BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16390942)

  • 1. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.
    Piersimoni C; Olivieri A; Benacchio L; Scarparo C
    J Clin Microbiol; 2006 Jan; 44(1):20-8. PubMed ID: 16390942
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy.
    Johansen IS; Thomsen VØ; Marjamäki M; Sosnovskaja A; Lundgren B
    Diagn Microbiol Infect Dis; 2004 Oct; 50(2):103-7. PubMed ID: 15474318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis].
    Gui XH; Xu P; Zhao M; Wang LL; Wu J; Li J; Gao Q; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jan; 33(1):43-5. PubMed ID: 20368024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.
    Garrigó M; Aragón LM; Alcaide F; Borrell S; Cardeñosa E; Galán JJ; Gonzalez-Martín J; Martin-Casabona N; Moreno C; Salvado M; Coll P
    J Clin Microbiol; 2007 Jun; 45(6):1766-70. PubMed ID: 17442793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the manual Mycobacteria Growth Indicator tube and the Etest with the method of proportion for susceptibility testing of Mycobacterium tuberculosis.
    Fegou E; Jelastopulu E; Nicolaou S; Sevdali M; Anagnostou S; Kanavaki S; Dimitracopoulos G; Spiliopoulou I
    Chemotherapy; 2006; 52(4):174-7. PubMed ID: 16675901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a novel kit for use with the BacT/ALERT 3D system for drug susceptibility testing of Mycobacterium tuberculosis.
    Werngren J; Klintz L; Hoffner SE
    J Clin Microbiol; 2006 Jun; 44(6):2130-2. PubMed ID: 16757609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Culture and susceptibility testing of mycobacteria with VersaTREK].
    Gravet A; Souillard N; Habermacher J; Moser A; Lohmann C; Schmitt F; Delarbre JM
    Pathol Biol (Paris); 2011 Feb; 59(1):32-8. PubMed ID: 20850229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the MGIT 960 system improve the turnaround times for growth detection and susceptibility testing of the Mycobacterium tuberculosis complex?
    Somoskovi A; Clobridge A; Larsen SC; Sinyavskiy O; Surucuoglu S; Parsons LM; Salfinger M
    J Clin Microbiol; 2006 Jun; 44(6):2314-5. PubMed ID: 16757650
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of MGIT 960 and the colorimetric-based method for tuberculosis drug susceptibility testing.
    Morcillo N; Imperiale B; Di Giulio B
    Int J Tuberc Lung Dis; 2010 Sep; 14(9):1169-75. PubMed ID: 20819264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of nitrate reductase and automatic BACTEC MGIT 960 AST techniques for determining the drug sensitivity of mycobacteria tuberculosis].
    Golyshevskaia VI; Irtuganova OA; Smirnova NS; Domotenko LV
    Probl Tuberk Bolezn Legk; 2003; (8):34-7. PubMed ID: 14524099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the GenoCard as a tool for transport and storage of samples for tuberculosis molecular drug susceptibility testing.
    Miotto P; Piana F; Migliori GB; Cirillo DM
    New Microbiol; 2008 Jan; 31(1):147-50. PubMed ID: 18437855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress in the study of drug susceptibility testing of Mycobacterium tuberculosis].
    Zhang YY; Wan KL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1074-7. PubMed ID: 15769370
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial susceptibility testing of Mycobacterium tuberculosis to first-line drugs: comparisons of the MGIT 960 and BACTEC 460 systems.
    Huang TS; Tu HZ; Lee SS; Huang WK; Liu YC
    Ann Clin Lab Sci; 2002; 32(2):142-7. PubMed ID: 12017195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comment on: isoniazid and rifampicin resistance-associated mutations in Mycobacterium tuberculosis isolates from Yangon, Myanmar: implications for rapid molecular testing.
    Köser CU; Summers DK; Archer JA
    J Antimicrob Chemother; 2011 Mar; 66(3):686-7; author reply 687. PubMed ID: 21177677
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
    Hillemann D; Rüsch-Gerdes S; Richter E
    J Clin Microbiol; 2007 Aug; 45(8):2635-40. PubMed ID: 17537937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Mycobacteria Growth Indicator Tube (MGIT) for drug susceptibility testing of Mycobacterium tuberculosis.
    Palomino JC; Traore H; Fissette K; Portaels F
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):344-8. PubMed ID: 10206506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy.
    Miotto P; Piana F; Penati V; Canducci F; Migliori GB; Cirillo DM
    J Clin Microbiol; 2006 Jul; 44(7):2485-91. PubMed ID: 16825369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicentre evaluation of an automated BACTEC 960 system for susceptibility testing of Mycobacterium tuberculosis.
    Giampaglia CM; Martins MC; Vieira GB; Vinhas SA; Telles MA; Palaci M; Marsico AG; Hadad DJ; Mello FC; Fonseca Lde S; Kritski A
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):986-91. PubMed ID: 17705976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-house phage amplification assay is a sound alternative for detecting rifampin-resistant Mycobacterium tuberculosis in low-resource settings.
    Símboli N; Takiff H; McNerney R; López B; Martin A; Palomino JC; Barrera L; Ritacco V
    Antimicrob Agents Chemother; 2005 Jan; 49(1):425-7. PubMed ID: 15616326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.